succinimidyl 4-(p-maleimidophenyl)butyrate
succinimidyl 4-(p-maleimidophenyl)butyrate structure
|
Common Name | succinimidyl 4-(p-maleimidophenyl)butyrate | ||
|---|---|---|---|---|
| CAS Number | 79886-55-8 | Molecular Weight | 356.329 | |
| Density | 1.5±0.1 g/cm3 | Boiling Point | 551.1±60.0 °C at 760 mmHg | |
| Molecular Formula | C18H16N2O6 | Melting Point | 130-131ºC | |
| MSDS | Chinese USA | Flash Point | 287.1±32.9 °C | |
| Symbol |
GHS07 |
Signal Word | Warning | |
Use of succinimidyl 4-(p-maleimidophenyl)butyrateSMPB crosslinker, or N-Succinimidyl 4-[4-maleimidophenyl]butyrate, is a heterobifunctional protein crosslinking reagent that is reactive toward sulfhydryl and amino groups. SMPB crosslinker's spacer arm is non cleavable. The SMPB protein crosslinker is an extended chain length analog of MBS crosslinker. |
| Name | 4-(4-Maleimidophenyl)butyric Acid N-Succinimidyl Ester |
|---|---|
| Synonym | More Synonyms |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 551.1±60.0 °C at 760 mmHg |
| Melting Point | 130-131ºC |
| Molecular Formula | C18H16N2O6 |
| Molecular Weight | 356.329 |
| Flash Point | 287.1±32.9 °C |
| Exact Mass | 356.100830 |
| PSA | 101.06000 |
| LogP | -0.31 |
| Vapour Pressure | 0.0±1.5 mmHg at 25°C |
| Index of Refraction | 1.637 |
| Storage condition | 2-8°C |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H315-H319-H335 |
| Precautionary Statements | P261-P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xi: Irritant; |
| Risk Phrases | R36/37/38 |
| Safety Phrases | 26-36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
|
Development of pro-apoptotic peptides as potential therapy for peritoneal endometriosis.
Nat. Commun. 5 , 4478, (2014) Endometriosis is a common gynaecological disease associated with pelvic pain and infertility. Current treatments include oral contraceptives combined with nonsteroidal anti-inflammatory drugs or surge... |
|
|
AFM imaging of immobilized fibronectin: does the surface conjugation scheme affect the protein orientation/conformation?
Langmuir 23(19) , 9745-51, (2007) Covalent grafting of biomolecules could potentially improve the biocompatibility of materials. However, these molecules have to be grafted in an active conformation to play their biological roles. The... |
|
|
Herceptin-conjugated temperature-sensitive immunoliposomes encapsulating gemcitabine for breast cancer.
Arch. Pharm. Res. 39 , 350-8, (2016) Gemcitabine (2',2'-difluorodeoxycytidine, GCT) is an analog of deoxycytidine with cytotoxicity for breast cancer cells. However, because of its hepatotoxicity and other side effects, an efficient drug... |
| MFCD00054961 |
| succinimidyl 4-(p-maleimidophenyl)butyrate |
| N-Succinimidyl 4-(4-maleimidophenyl)butyrate |
| 1-(4-{4-[(2,5-Dioxo-1-pyrrolidinyl)oxy]-4-oxobutyl}phenyl)-1H-pyrrole-2,5-dione |
| 1H-Pyrrole-2,5-dione, 1-(4-(4-((2,5-dioxo-1-pyrrolidinyl)oxy)-4-oxobutyl)phenyl)- |
| 1H-Pyrrole-2,5-dione, 1-[4-[4-[(2,5-dioxo-1-pyrrolidinyl)oxy]-4-oxobutyl]phenyl]- |